Article

You have full text access to this OnlineOpen article

Characterizing and controlling the inherent dynamics of cyclophilin-A

  1. Jennifer Schlegel1,
  2. Geoffrey S. Armstrong2,
  3. Jasmina S. Redzic1,
  4. Fengli Zhang3,
  5. Elan Zohar Eisenmesser1,*

Article first published online: 12 FEB 2009

DOI: 10.1002/pro.89

Issue

Protein Science

Protein Science

Volume 18, Issue 4, pages 811–824, April 2009

Additional Information

How to Cite

Schlegel, J., Armstrong, G. S., Redzic, J. S., Zhang, F. and Eisenmesser, E. Z. (2009), Characterizing and controlling the inherent dynamics of cyclophilin-A. Protein Science, 18: 811–824. doi: 10.1002/pro.89

Author Information

  1. 1

    Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, Colorado 80045

  2. 2

    Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado 80309

  3. 3

    National High Magnetic Field Laboratory, Tallahassee, Florida 32310

*Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Health Sciences Center, Aurora, CO 80045

Publication History

  1. Issue published online: 25 MAR 2009
  2. Article first published online: 12 FEB 2009
  3. Accepted manuscript online: 12 FEB 2009 12:00AM EST
  4. Manuscript Accepted: 17 JAN 2009
  5. Manuscript Revised: 15 JAN 2009
  6. Manuscript Received: 23 SEP 2008

Funded by

  • NSF. Grant Number: MCB-0820567

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (832K)

References

  • 1
    Grey MJ, Wang CY, Palmer AG ( 2003) Disulfide bond isomerization in basic pancreatic trypsin inhibitor: multisite chemical exchange quantified by CPMG relaxation dispersion and chemical shift modeling. J Am Chem Soc 125: 14324–14335.
  • 2
    Hill RB, Bracken C, DeGrado WF, Palmer AG ( 2000) Molecular motions and protein folding: characterization of the backbone dynamics and folding equilibrium of alpha D-2 using C-13 NMR spin relaxation. J Am Chem Soc 122: 11610–11619.
  • 3
    Tollinger M, Skrynnikov NR, Mulder FAA, Forman-Kay JD, Kay LE ( 2001) Slow dynamics in folded and unfolded states of an SH3 domain. J Am Chem Soc 123: 11341– 11352.
  • 4
    Korzhnev DM, Karlsson BG, Orekhov VY, Billeter M ( 2003) NMR detection of multiple transitions to low-populated states in azurin. Protein Sci 12: 56–65.
    Direct Link:
  • 5
    Korzhnev DM, Neudecker P, Zarrine-Afsar A, Davidson AR, Kay LE ( 2006b) Abp1p and fyn SH3 domains fold through similar low-populated intermediate states. Biochemistry 45: 10175–10183.
  • 6
    Lundstrom P, Akke M ( 2005) Off-resonance rotating-frame amide proton spin relaxation experiments measuring microsecond chemical exchange in proteins. J Biomol NMR 32: 163–173.
  • 7
    Belshaw PJ, Meyer SD, Johnson DD, Romo D, Ikeda Y, Andrus M, Alberg DG, Schultz LW, Clardy J, Schreiber SL ( 1994) Synthesis, structure and mechanism in immunophilin research. Synlett 381-392.
  • 8
    Eisenmesser EZ, Millet O, Labeikovsky W, Korzhnev DM, Wolf-Watz M, Bosco DA, Skalicky JJ, Kay LE, Kern D ( 2005) Intrinsic dynamics of an enzyme underlies catalysis. Nature 438: 117–121.
  • 9
    Boehr DD, McElheny D, Dyson HJ, Wright PE ( 2006b) The dynamic energy landscape of dihydrofolate reductase catalysis. Science 313: 1638–1642.
  • 10
    Boehr DD, Dyson HJ, Wright PE ( 2006a) An NMR perspective on enzyme dynamics. Chem Rev 106: 3055– 3079.
  • 11
    Cole R, Loria JP ( 2002) Evidence for flexibility in the function of ribonuclease A. Biochemistry 41: 6072–6081.
  • 12
    Beach H, Cole R, Gill ML, Loria JP ( 2005) Conservation of mu s-ms enzyme motions in the apo- and substrate-mimicked state. J Am Chem Soc 127: 9167–9176.
  • 13
    Kovrigin EL, Loria JP ( 2006) Enzyme dynamics along the reaction coordinate: critical role of a conserved residue. Biochemistry 45: 2636–2647.
  • 14
    Eisenmesser EZ, Bosco DA, Akke M, Kern D ( 2002) Enzyme dynamics during catalysis. Science 295: 1520– 1523.
  • 15
    Andreotti AH ( 2003) Native state proline isomerization: an intrinsic molecular switch. Biochemistry 42: 9515–9524.
  • 16
    Yao QZ, Li M, Yang H, Chai H, Fisher W, Chen CY ( 2005) Roles of cyclophilins in cancers and other organ systems. World J Surg 29: 276–280.
  • 17
    Yurchenko V, Constant S, Bukrinsky M ( 2006) Dealing with the family: CD147 interactions with cyclophilins. Immunology 117: 301–309.
    Direct Link:
  • 18
    Guichou JF, Viaud J, Mettling C, Subra G, Lin YL, Chavanieu A ( 2006) Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J Med Chem 49: 900–910.
  • 19
    Chen SA, Zhao XM, Tan JZ, Lu H, Qi Z, Huang Q, Zeng XZ, Zhang MJ, Jiang SB, Jiang HL, Yu L ( 2007) Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Eur J Pharmacol 565: 54–59.
  • 20
    Carver JP, Richards RE ( 1972) A General two-site solution for the chemical exchange produced dependence of T2 upon the Carr–Purcell pulse seperation. J Magn Reson 6: 89–105.
  • 21
    Jen J ( 1978) Chemical exchange and NMR T2 Relaxation—multisite case. J Magn Reson 30: 111–128.
  • 22
    Davis DG, Perlman ME, London RE ( 1994) Direct measurements of the dissociation-rate constant for inhibitor-enzyme complexes via the T-1-Rho and T-2 (Cpmg) methods. J Magn Reson Ser B 104: 266–275.
  • 23
    Millet O, Loria JP, Kroenke CD, Pons M, Palmer AG ( 2000) The static magnetic field dependence of chemical exchange linebroadening defines the NMR chemical shift time scale. J Am Chem Soc 122: 2867–2877.
  • 24
    Zhao Y, Ke H ( 1996a) Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization. Biochemistry 35: 7356–7361.
  • 25
    Zhao YD, Ke HM ( 1996b) Mechanistic implication of crystal structures of the cyclophilin-dipeptide complexes. Biochemistry 35: 7362–7368.
  • 26
    Kovrigin EL, Kempf JG, Grey MJ, Loria JP ( 2006) Faithful estimation of dynamics parameters from CPMG relaxation dispersion measurements. J Magn Reson 180: 93–104.
  • 27
    Skrynnikov NR, Dahlquist FW, Kay LE ( 2002) Reconstructing NMR spectra of “invisible” excited protein states using HSQC and HMQC experiments. J Am Chem Soc 124: 12352–12360.
  • 28
    Berger C, Weber-Bornhauser S, Eggenberger J, Hanes J, Pluckthun A, Bosshard HR ( 1999) Antigen recognition by conformational selection. FEBS Lett 450: 149–153.
  • 29
    Kern D, Kern G, Scherer G, Fischer G, Drakenberg T ( 1995) Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy. Biochemistry 34: 13594–13602.
  • 30
    Monod J, Wynam J, Changeux J-P ( 1965). On the nature of allosteric transitions: a plausible model. J Mol Biol 12: 88–118.
  • 31
    Korzhnev DM, Bezsonova I, Evanics F, Taulier N, Zhou Z, Bai YW, Chalikian TV, Prosser RS, Kay LE ( 2006a) Probing the transition state ensemble of a protein folding reaction by pressure-dependent NMR relaxation dispersion. J Am Chem Soc 128: 5262–5269.
  • 32
    Gamble TR, Vajdos FF, Yoo SH, Worthylake DK, Houseweart M, Sundquist WI, Hill CP ( 1996) Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87: 1285–1294.
  • 33
    Ke HM, Huai Q ( 2004) Crystal structures of cyclophilin and its partners. Front Biosci 9: 2285–2296.
  • 34
    Howard BR, Vajdos FF, Li S, Sundquist WI, Hill CP ( 2003) Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol 10: 475–481.
  • 35
    Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI, Walsh CT ( 1992) Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1: 1092–1099.
    Direct Link:
  • 36
    Piotukh K, Gu W, Kofler M, Labudde D, Helms V, Freund C ( 2005) Cyclophilin a binds to linear peptide motifs containing a consensus that is present in many human proteins. J Biol Chem 280: 23668–23674.
  • 37
    Loria JP, Rance M, Palmer AG ( 1999b) A TROSY CPMG sequence for characterizing chemical exchange in large proteins. J Biomol NMR 15: 151–155.
  • 38
    Loria JP, Rance M, Palmer AG ( 1999a) A relaxation-compensated Carr-Purcell-Meiboom-Gill sequence for characterizing chemical exchange by NMR spectroscopy. J Am Chem Soc 121: 2331–2332.
  • 39
    Wang CY, Palmer AG ( 2003) Solution NMR methods for quantitative identification of chemical exchange in N-15-labeled proteins. Magn Reson Chem 41: 866– 876.
    Direct Link:
  • 40
    Mulder FAA, Skrynnikov NR, Hon B, Dahlquist FW, Kay LE ( 2001) Measurement of slow (mu s-ms) time scale dynamics in protein side chains by N-15 relaxation dispersion NMR spectroscopy: Application to Asn and Gln residues in a cavity mutant of T4 lysozyme. J Am Chem Soc 123: 967–975.
  • 41
    Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A ( 1995) NMRPipe - a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277–293.
  • 42
    Luz Z, Meiboom S ( 1963) Nuclear magnetic resonance study of the protolysis of trimethylammonium ion in acqueous solution-order of the reaction with respect to solvent. J Chem Phys 39: 366–370.
  • 43
    Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas P, Ulrich EL, Markley JL, Ionides J, Laue ED ( 2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins-Structure Function and Bioinformatics 59: 687–696.
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (832K)